MALDI-TOF/TOF Mass Spectrometer

Perhaps no tool has been as instrumental to the proteomics revolution as the mass spectrometer. With the ability to deconvolute highly complex mixtures over a wide range of abundance levels, these machines enable researchers to identify and quantify proteins and to determine if and how those proteins have been post-translationally modified.The basic mass spectrometer measures an ion's mass-to-charge (m/z) ratio only. This enables peptide mass fingerprinting, which is the identification of a prot

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Perhaps no tool has been as instrumental to the proteomics revolution as the mass spectrometer. With the ability to deconvolute highly complex mixtures over a wide range of abundance levels, these machines enable researchers to identify and quantify proteins and to determine if and how those proteins have been post-translationally modified.

The basic mass spectrometer measures an ion's mass-to-charge (m/z) ratio only. This enables peptide mass fingerprinting, which is the identification of a protein based on the specific group of peptide masses it produces. But tandem devices, the so-called MS/MS instruments, can provide peptide sequence information as well. The key components shown on these pages demonstrate one of these instruments: the 4700 Proteomics Analyzer made by Applied Biosystems of Foster City, Calif., which features a MALDI (matrix-assisted laser desorption ionization) source and tandem time-of-flight (TOF/TOF) mass analyzers.

1 The process typically begins either with a protein spot extracted from a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies